Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245944 · ClinicalTrials.gov registry record · NA
Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas
A NA study of Immature Arteriovenous Fistula, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT03245944 is a NA study of Immature Arteriovenous Fistula that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03245944, a NA study of Immature Arteriovenous Fistula, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. The optimal timing of intervention to salvage immature AVFs is unknown.The study proposes a randomized clinical trial comparing the clinical and economic impact of early vs late angioplasty in non-maturing AVFs. The study proposes a RCT to test the hypothesis that, as compared to early angioplasty of non-maturing AVFs, late angioplasty results in a lower proportion of AVFs being used at 6 months, but a greater long-term AVF patency , lower requirement of subsequent interventions to maintain AVF patency for dialysis, and lower overall cost of access maintenance.
Conditions Studied
Interventions
- PROCEDURE early Angioplasty
- PROCEDURE late Angioplasty
Study Locations (1)
Alabama
- UAB - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03245944
The ClinicalTrials.gov registry entry for NCT03245944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immature Arteriovenous Fistula appearing as the primary indexed condition, and to 2 interventions - of which early Angioplasty is the first listed.
NCT03245944 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03245944 about?
NCT03245944 is a clinical study titled "Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas". Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. The optimal timing of intervention to salvage immature AVFs is unknown.The study proposes a randomized clinical trial comparing the clinical and economic impact of early vs late ang...
What is the current status of trial NCT03245944?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-03-01. Estimated completion is 2020-03-01.
What conditions does trial NCT03245944 study?
This clinical trial studies the following conditions: Immature Arteriovenous Fistula.
What interventions are being tested in trial NCT03245944?
The interventions under investigation include: early Angioplasty (PROCEDURE), late Angioplasty (PROCEDURE).
Who is sponsoring clinical trial NCT03245944?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03245944 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.